Sergio Zacà

ORCID: 0000-0002-9038-8306
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Aortic aneurysm repair treatments
  • Cardiac, Anesthesia and Surgical Outcomes
  • Aortic Disease and Treatment Approaches
  • Peripheral Artery Disease Management
  • Vascular Procedures and Complications
  • Infectious Aortic and Vascular Conditions
  • Cerebrovascular and Carotid Artery Diseases
  • Cardiovascular Health and Disease Prevention
  • Venous Thromboembolism Diagnosis and Management
  • Acute Ischemic Stroke Management
  • Renal and Vascular Pathologies
  • Cardiac Valve Diseases and Treatments
  • Blood Pressure and Hypertension Studies
  • COVID-19 and healthcare impacts
  • HIV-related health complications and treatments
  • Abdominal vascular conditions and treatments
  • Machine Learning in Healthcare
  • Intracranial Aneurysms: Treatment and Complications
  • Anesthesia and Pain Management
  • Aortic Thrombus and Embolism
  • Health Systems, Economic Evaluations, Quality of Life
  • Diabetes and associated disorders
  • Trauma and Emergency Care Studies
  • Lipoproteins and Cardiovascular Health
  • Musculoskeletal Disorders and Rehabilitation

University of Bari Aldo Moro
2019-2025

Purpose: To report the results of endovascular treatment iliac and complex aortoiliac occlusive disease (AIOD) in a multicenter Italian registry. Materials Methods: A retrospective, multicenter, observational cohort study analyzed 713 patients (mean age 68±10 years; 539 men) with isolated lesions treated primary stenting between January 2015 December 2017. Indications for were claudication 406 (57%) critical limb ischemia 307 (43%). According to TransAtlantic Inter-Society Consensus II...

10.1177/1526602819863081 article EN Journal of Endovascular Therapy 2019-07-22

Objectives: To analyze the incidence and predictive factors of postoperative acute kidney injury (AKI) after elective standard endovascular aortic repair (EVAR) in a large recent, multicenter cohort. Materials Methods: This is multicenter, retrospective, financially unsupported physician-initiated observational cohort study. Between January 2018 March 2021, only patients treated with EVAR for infrarenal non-infected abdominal aneurysm were analyzed. Patients already on hemodialysis (HD)...

10.1177/15266028241234277 article EN Journal of Endovascular Therapy 2024-02-26

BACKGROUND: To estimate the impact of anesthetic conduct, alone and in combination with type femoral access, on early results after endovascular aneurysm repair (EVAR).METHODS: A retrospective multicenter analysis patients undergoing elective standard EVAR at four academic centers was performed. Patients procedure through either local or general anesthesia were compared. Comparative subanalyses two groups performed for access to evaluate further outcomes.RESULTS: Five hundred twenty-four...

10.23736/s0392-9590.24.05134-4 article EN International Angiology 2024-03-08

Background: Antiretroviral therapy has allowed a clear improvement in prognosis for HIV patients, but metabolic problems, such as dyslipidemia, remain. This can lead to the development of atheromatous plaques. Our study aims evaluate whether HIV-positive (HIV+) patients show higher myo-intimal media thickness (IMT) and plaques compared HIV-negative (HIV−) patients. Methods: To association between infection experienced vascular pathology, we performed cross-sectional study, observing 1006 380...

10.3390/biomedicines12040773 article EN cc-by Biomedicines 2024-04-01

Purpose: Endovascular aortic repair (EVAR) is currently expanding its feasibility thanks to design innovations, but hostile proximal necks and narrow iliac arteries are still a constraint, as expressed by the Instructions for Use (IFU) of most devices. Our aim report preliminary results E-Tegra endograft in infrarenal abdominal aneurysms (AAAs) performed 15 high-volume centers. Materials Methods: The e-Tegra Italian endoGraft REgistry (TIGRE) prospectively maintained database consecutive...

10.1177/15266028241270861 article EN Journal of Endovascular Therapy 2024-08-27

A narrowed patent aortic lumen (<25 mm) represents a challenging scenario frequently observed during thoraco-abdominal and abdominal pathologies involving the visceral vessels. The paper aims to describe characteristics of novel tapered-shape inner-branched custom-made stent-graft designed specifically address its applicability in wider spectrum scenarios at reno-visceral segment.

10.1093/ejcts/ezae429 article EN European Journal of Cardio-Thoracic Surgery 2024-11-28

To analyze outcomes following endovascular treatment of total occlusion the infrarenal aorta and aorto-iliac bifurcation in a multicenter Italian registry.It is multicenter, retrospective, observational cohort study. From January 2015 to December 2018, 1306 interventions for occlusive disease were recorded vascular registry. For this analysis, only patients treated included. Early (<30 days) primary interest technical success mortality. Late major secondary patency freedom from conversion...

10.1177/15266028211059908 article EN Journal of Endovascular Therapy 2021-12-01

Objective: To report on the recommendations of an expert-based consensus indications, timing, and techniques aortic balloon occlusion (ABO) in management ruptured abdominal aneurysms (rAAA). Methods: Eleven facilitators created appropriate statements regarding study issues that were voted using a 4-point Likert scale with open-comment fields, by selected panel international experts (vascular surgeons interventional radiologists) 3-round modified Delphi procedure (study period: January-April...

10.1177/15266028231217233 article EN Journal of Endovascular Therapy 2023-12-07
Ruth Benson Maria Antonella Ruffino Sharon Chan Patrick A. Coughlin Ayoola Awopetu and 95 more Philip Stather Tristan Lane Dimitrios Theodosiou Mohamed Abozeid Ahmed Thodur Vasudevan Mohammed Auwal Ibrahim Faraj Al maadany Mohamed Eljareh Fatimah Saad Alkhafeefi Raphaël Coscas Ertekin Utku Ünal Raffaele Pulli Sergio Zacà Domenico Angiletta Thomas Kotsis Magdy Moawad Matteo Tozzi Nikolaos Patelis Andreas Lazaris Jason Chuen Alexander Croo Elpiniki Tsolaki Gladiol Zenunaj Dhafer Kamal Mahmoud M. Tolba Martin Maresch Vipul Khetarpaul Joseph L. Mills Gaurav Gangwani Mohamed Elahwal Rana Khalil Mohammed A. Azab Anver Mahomed R J Whiston Ummul Contractor Davide Esposito Carlo Pratesi Elena Giacomelli Martín Veras Troncoso Stéphane Elkouri Flavia Gentile Johansson Ilias Dodos Marie Benezit José Vidoedo João Rocha‐Neves António Pereira-Neves Marina Dias‐Neto Ana Filipa Campos Jácome Luís Loureiro Ivone Silva Rodrigo Garza-Herrera Victor Canata Charlotte Bezard Kathryn E. Bowser Jorge Felipe Tobar Carlos Gomez Vera Carolina Salinas Parra Eugenia Lopez Yvis Gadelha Serra Juan Pablo Uzcátegui Varela Vanessa Rubio Gerardo Victoria Adam P. Johnson Leigh Ann O’Banion Ragai Makar Tamer Ghatwary Tantawy Martin Störck Vincent Jongkind Orwa falah Olivia McBride Arda Işık Αθανάσιος Παπαϊωάννου Paulo Eduardo Ocke Reis Umberto Bracale Ellie Atkins Giovanni Tinelli Emma Scott Lucy Wales Ashwin Sivaharan Georgia Priona Craig Nesbitt Tabitha Grainger Lauren Shelmerdine Patrick Chong Adnan Bajwa Luke Arwynck Nancy Hadjievangelou Ahmed Elbasty Óscar Bajo Rubio Michael Ricardo Jorge H Ulloa Marcos Manuel Tarazona Manuel Pabon Georgios A. Pitoulias Kevin Corless

To document the recovery of vascular services in Europe following first COVID-19 pandemic peak.An online structured service survey with repeated data entry between 23 March and 9 August 2020 was carried out. Unit level were collected using questionnaires addressing modifications to during peak (March - May 2020, "period 1"), then again June ("period 2") July 3"). The duration each period similar. From 2 June, as reductions cases began be reported, centres asked if they a region still...

10.1016/j.ejvsvf.2022.10.002 article EN cc-by-nc-nd EJVES Vascular Forum 2022-01-01

Abstract OBJECTIVES To evaluate gender-related outcomes during endovascular treatment of thoracic and thoraco-abdominal aortic diseases (TEVAR). METHODS Multicentre, retrospective, observational cohort study. All TEVARs between January 2005 April 2023 were identified. Primary 30-day mortality, cumulative survival. Secondary vascular access complications, freedom from TEVAR-related reintervention. Interventions performed in male patients matched to females on the basis a one-to-one coarsened...

10.1093/ejcts/ezae343 article EN European Journal of Cardio-Thoracic Surgery 2024-09-25
Coming Soon ...